Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
Thomas S. Uldrick, Scott V. Adams, Rémi Fromentin, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 629
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Phenotypic signatures of immune selection in HIV-1 reservoir cells
Weiwei Sun, Ce Gao, Ciputra Adijaya Hartana, et al.
Nature (2023) Vol. 614, Iss. 7947, pp. 309-317
Open Access | Times Cited: 96
Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure
Marie Armani-Tourret, Benjamin Bone, Toong Seng Tan, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 6, pp. 328-344
Closed Access | Times Cited: 19
HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an “Emerging Syndemic”
José Miguel Azevedo‐Pereira, David Pires, Marta Calado, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 853-853
Open Access | Times Cited: 30
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
Talal El Zarif, Amin H. Nassar, Elio Adib, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 21, pp. 3712-3723
Open Access | Times Cited: 30
PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication
Lori A. Emert‐Sedlak, Colin M. Tice, Haibin Shi, et al.
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 658-668.e14
Open Access | Times Cited: 7
The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
Quinten Debrabander, Kathryn S. Hensley, Christina Psomas, et al.
Journal of Virus Eradication (2023) Vol. 9, Iss. 3, pp. 100342-100342
Open Access | Times Cited: 19
Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
Blossom Damania, Dirk P. Dittmer
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Open Access | Times Cited: 15
Inhibition of SFTSV replication in humanized mice by a subcutaneously administered anti-PD1 nanobody
Mengmeng Ji, J L Hu, Doudou Zhang, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 3, pp. 575-595
Open Access | Times Cited: 5
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption
Susan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, et al.
Nature Immunology (2024) Vol. 25, Iss. 10, pp. 1900-1912
Open Access | Times Cited: 5
Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places
Wenxuan Chen, Ben Berkhout, Alexander Pasternak
Current HIV/AIDS Reports (2025) Vol. 22, Iss. 1
Open Access
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy
Thessa Laeremans, A Janssens, Joeri L. Aerts
Immunotherapy (2025), pp. 1-13
Closed Access
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
Ramya Ramaswami, Angela Shaulov Kask, Leonard D’Amico, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010291-e010291
Open Access
Activating PKC-ε induces HIV expression with improved tolerability
Alivelu Irrinki, Jasmine Kaur, Baljit Randhawa, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 2, pp. e1012874-e1012874
Open Access
Treating Cancer in People With HIV
Kathryn Lurain
Journal of Clinical Oncology (2023) Vol. 41, Iss. 21, pp. 3682-3688
Open Access | Times Cited: 12
Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4
Katie Fisher, Timothy E. Schlub, Zoe Boyer, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Malignancy and viral infections in Sub-Saharan Africa: A review
Mahamadou Diakité, Kathryn Shaw‐Saliba, Chuen‐Yen Lau
Frontiers in Virology (2023) Vol. 3
Open Access | Times Cited: 10
Proviral location affects cognate peptide–induced virus production and immune recognition of HIV-1–infected T cell clones
Filippo Dragoni, Abena K. Kwaa, Caroline C. Traut, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access | Times Cited: 10
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy
Cynthia L. Gay, Ronald J. Bosch, Ashley McKhann, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 3
Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV
Chaoyu Chen, Jiangrong Wang, Jingna Xun, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States
Kathryn Lurain, Talal El Zarif, Ramya Ramaswami, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 8, pp. 523-530
Closed Access | Times Cited: 3
The role of latency reversal in HIV cure strategies
Kiho Tanaka, Youry Kim, Michael Roche, et al.
Journal of Medical Primatology (2022) Vol. 51, Iss. 5, pp. 278-283
Open Access | Times Cited: 17
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
Catherine A. Lewis, David M. Margolis, Edward P. Browne
Viruses (2023) Vol. 15, Iss. 8, pp. 1677-1677
Open Access | Times Cited: 9
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 9
The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
Allison L. Balasko, Monika M. Kowatsch, Colin Graydon, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
A novel high-throughput microwell outgrowth assay for HIV-infected cells
Anthony D. Fenton, Nancie M. Archin, Anne‐Marie W. Turner, et al.
Journal of Virology (2024) Vol. 98, Iss. 3
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top